Participants
The parents of 45 consecutive children with solid and haematological
tumors treated in the Pediatric Oncology, Pediatric Neurosurgery, and
Radiotherapy Unit of Fondazione Policlinico Universitario A. Gemelli
IRCCS in Rome were enrolled in the study. Criteria for selecting the
subjects were: 1) parent of a patient with a cancer diagnosis; 2) parent
of a patient who was in treatment or had completed their treatment
regimen; and 3) parent of patients < 25 years of age.
Parents with psychiatric or cognitive disorders or intellectual
disability were excluded from the study.
This study was performed in accordance with the Helsinki declaration and
approved by the Institutional Review Board. Written informed consent was
obtained from all participants.